Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00430326Phase 2Completed
A Phase 2 trial of avotermin in cicatrix, sponsored by Renovo. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00430326.